Bivalent CD47 Immunotoxin for Targeted Therapy of T-Cell Acute Lymphoblastic Leukemia. Ma J, Wang Z, Mintzlaff D, Zhang H, et al. Blood 2024 Nov 19:blood.2024025277. doi: 10.1182/blood.2024025277.

Read + Share

Amedeo Smart

Independent Medical Education

Ma J, Wang Z, Mintzlaff D, Zhang H, et al. Bivalent CD47 Immunotoxin for Targeted Therapy of T-Cell Acute Lymphoblastic Leukemia. Blood 2024 Nov 19:blood.2024025277. doi: 10.1182/blood.2024025277.
PMID: 39561285